Lipid composition heatmap for Study ST003436

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Sample source:FBS-based standard | Sample Type:FBS-based standard | Drug Treatment:NA | Time post-injection:NA
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h
Sample source:Murine brain | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h
Sample source:Murine heart | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:15 min
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:1 h
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:2 h
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:3 h
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:4 h
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:10 mg/kg Fasnall | Time post-injection:6 h
Sample source:Murine liver | Sample Type:Tissue metabolite extract | Drug Treatment:Control | Time post-injection:NA
Sample source:Murine plasma | Sample Type:Plasma-based standard | Drug Treatment:NA | Time post-injection:NA
Sample source:Murine plasma | Sample Type:Plasma | Drug Treatment:NA | Time post-injection:NA
Sample source:NA | Sample Type:Blank | Drug Treatment:NA | Time post-injection:NA
Sample source:NA | Sample Type:QC | Drug Treatment:NA | Time post-injection:NA
Sample source:QC | Sample Type:QC | Drug Treatment:NA | Time post-injection:NA
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines24
Saturated FA10
Unsaturated FA1
  logo